116 related articles for article (PubMed ID: 7638434)
1. Dose-dependent systemic human immunodeficiency virus infection of SCID-hu mice after intraperitoneal virus injection.
Grandadam M; Cesbron JY; Candotti D; Vinatier D; Pauchard M; Capron A; Debré P; Huraux JM; Autran B; Agut H
Res Virol; 1995; 146(2):101-12. PubMed ID: 7638434
[TBL] [Abstract][Full Text] [Related]
2. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1.
Kollmann TR; Pettoello-Mantovani M; Zhuang X; Kim A; Hachamovitch M; Smarnworawong P; Rubinstein A; Goldstein H
J Exp Med; 1994 Feb; 179(2):513-22. PubMed ID: 8294863
[TBL] [Abstract][Full Text] [Related]
3. Saquinavir-mediated inhibition of human immunodeficiency virus (HIV) infection in SCID mice implanted with human fetal thymus and liver tissue: an in vivo model for evaluating the effect of drug therapy on HIV infection in lymphoid tissues.
Pettoello-Mantovani M; Kollmann TR; Raker C; Kim A; Yurasov S; Tudor R; Wiltshire H; Goldstein H
Antimicrob Agents Chemother; 1997 Sep; 41(9):1880-7. PubMed ID: 9303378
[TBL] [Abstract][Full Text] [Related]
4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
5. The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides.
Chargui J; Dye D; Blomberg J; Desgranges C; Touraine JL
J Immunol Methods; 1995 Apr; 181(1):91-100. PubMed ID: 7730668
[TBL] [Abstract][Full Text] [Related]
6. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
[TBL] [Abstract][Full Text] [Related]
7. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
[TBL] [Abstract][Full Text] [Related]
8. Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model.
Autran B; Guiet P; Raphael M; Grandadam M; Agut H; Candotti D; Grenot P; Puech F; Debre P; Cesbron JY
AIDS; 1996 Jun; 10(7):717-27. PubMed ID: 8805862
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
Kollmann TR; Pettoello-Mantovani M; Katopodis NF; Hachamovitch M; Rubinstein A; Kim A; Goldstein H
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3126-31. PubMed ID: 8610180
[TBL] [Abstract][Full Text] [Related]
10. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
[TBL] [Abstract][Full Text] [Related]
13. SCID-Hu mouse as a model for human lung HIV-1 infection.
Cesbron JY; Agut H; Gosselin B; Candotti D; Raphaël M; Puech F; Grandadam M; Debré P; Capron A; Autran B
C R Acad Sci III; 1994 Jul; 317(7):669-74. PubMed ID: 7882151
[TBL] [Abstract][Full Text] [Related]
14. Loss of T cell receptor Vbeta repertoires in HIV type 1-infected SCID-hu mice.
Boldt-Houle DM; Jamieson BD; Aldrovandi GM; Rinaldo CR; Ehrlich GD; Zack JA
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):125-34. PubMed ID: 9007198
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells.
Wang EJ; Pettoello-Mantovani M; Anderson CM; Osiecki K; Moskowitz D; Goldstein H
J Infect Dis; 2002 Nov; 186(10):1412-21. PubMed ID: 12404156
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse.
Kaneshima H; Shih CC; Namikawa R; Rabin L; Outzen H; Machado SG; McCune JM
Proc Natl Acad Sci U S A; 1991 May; 88(10):4523-7. PubMed ID: 1903543
[TBL] [Abstract][Full Text] [Related]
17. SCID-hu mice: a model for studying disseminated HIV infection.
Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
[TBL] [Abstract][Full Text] [Related]
18. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS
J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
